AA
TAK icon

ABC Arbitrage’s Takeda Pharmaceutical TAK Stock Holding History

ABC Arbitrage’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-571,863
Closed -$8.37M – 412
2025
Q3 		$8.37M Buy
+571,863
New +$8.49M 0.82% 30
2025
Q2 		– Sell
-335,855
Closed -$4.99M – 265
2025
Q1 		$4.99M Buy
+335,855
New +$4.71M 0.93% 28

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ABC Arbitrage's TAK Position: Q4 2025 in Review

ABC Arbitrage sold out of Takeda Pharmaceutical (TAK) in Q4 2025, closing a stake of 571,863 shares — an estimated $8.37M sold.

ABC Arbitrage first reported a position in TAK in Q1 2025 and held it in 2 quarters. The position peaked at $8.37M in Q3 2025. 348 funds tracked by Wall St. Rank hold TAK as of Q4 2025.

  • ABC Arbitrage reported no remaining Takeda Pharmaceutical position as of Q4 2025 after selling out during the quarter.
  • ABC Arbitrage sold 571,863 Takeda Pharmaceutical shares in Q4 2025, an estimated $8.37M.
  • ABC Arbitrage first reported a position in Takeda Pharmaceutical in Q1 2025 and held it in 2 quarters.
  • ABC Arbitrage's Takeda Pharmaceutical position peaked at $8.37M in Q3 2025.
  • 348 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2025.

Based on ABC Arbitrage's 13F filing for Q4 2025, filed 4 Feb 2026.